What will you learn?
The University- Master's Degree te in Pharma-Biotech Business Management trains versatile professionals with analytical skills, work s in a team, a proactive attitude, and a commitment to ethics.
The program combines a solid academic training curriculum—taught by professors from the University of Navarra, IESE Business School, and industry professionals—with paid internships at business.
During the " Master's Degree ," you will gain knowledge in finance, marketing, accounting, and operations, and develop management, communication, leadership, and team work ation skills in the pharma-biotech sector.
In addition, since this is an official Master's Degree , it provides access to programs of study and doctorate.
The Pharma-Biotech sector has faced major changes in recent years that are generating a change of model and the rapid transformation of the sector: the irruption of the digital world in the value chain, new ways of communication and interaction with the patient, new ways of analysing and using data, reduction of product lifecycles, etc.
All these changes mean that the sector is demanding professionals with excellent scientific and business backgrounds who have developed skills such as resilience, flexibility, adaptability, negotiation and collaboration, global vision, analysis and decision-making.
|
Commercial |
Digital |
The programme uses the case method as a system of teaching, which consists of solving real problems involving thorough analysis of the facts and proposal of solutions and alternatives. To get the most out of it, student is required to prepare each case individually and then discuss it in a team before attend at discussion on class directed by the teacher. It is a process that enriches learning due to the contributions of the other class colleagues and the solution proposed by the teacher.
The profile of the students is varied, although they all share a biosanitary background: pharmacy, biotechnology, biomedical engineering, medicine, veterinary medicine, biochemistry, biology, biomedicine, chemistry, etc.
They come from both national and international universities: U. de Navarra, U. Complutense de Madrid, U. de Barcelona, U. de Alcalá de Henares, U. de Sevilla, U. Pompeu Fabra, U. CEU San Pablo, U. de Valencia, U. Politécnica de Madrid y de Valencia, U. College of London, Imperial College of London, U. Exeter, U. de Grenoble, among others.
Marta Alonso
Regulatory & Quality Manager for Iberia
Medtronic
Pascual Arellano
Director , Oncology Business Unit & Chief Marketing Officer · Lilly
Alejandra Bartolomé
Training Specialist
Roche
María Burgueño
Business Enabling Coach
Roche
Rosana Cabello
Medical Collaborations & Operations Leader
Roche
José Luis Cabero
Advisor
Biovance Capital
Javier del Río
Healthcare Executive & Board Member
Cardiva
Diana Garau
Healthcare Compliance Officer
Roche
Teresa Hernando
EMEA Compound Market Access Lead
Johnson & Johnson
Ana Irigaray
Senior Director Regulatory Affairs
BeOne Medicines
Carolina Masaveu
Business Unit Director
AstraZeneca
Nuria spanish medical residency program
Director , Specialty Care
Pfizer
Ana Mozetic
Partner
Simon-Kucher
Alicia Nieto
Market Access Associate Director
MSD
Enrique Ordieres
President
Cinfa
Rafael Parra
Market Access Head
Johnson & Johnson
Felipe Pastrana
Vice President & General Director
AbbVie Spain
Ángel Pérez
Founder & Leading Partner
Trascendent
Natalia Robledinos
Health Economics and Market Access Sr Lead
Johnson & Johnson
Leonor Rombert
Strategic Project Manager
Johnson & Johnson
Javier Suárez
Global Commercial Lead
Pfizer
Ruth Vicente
Scientific Project Manager
Roche
Álvaro Villergas
Oncology Marketing & Sales Director
GSK